Medicated Shampoo Market Report 2026

Medicated Shampoo Market Overview

• Medicated Shampoo market size has reached to $13.84 billion in 2025 • Expected to grow to $17.86 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Rising Prevalence Of Scalp Disorders Fueling The Growth Of The Market Due To Increasing Pollution And Skin Sensitivity • Market Trend: Innovative Medicated Dry Shampoos Revolutionizing Scalp Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medicated Shampoo Market?

Medicated shampoo refers to a type of shampoo that is specifically designed to treat various scalp and hair conditions by applying medicine directly to the scalp. These shampoos contain therapeutic ingredients or drugs that address issues such as dandruff, psoriasis, seborrheic dermatitis, fungal infections, and other scalp conditions. The main types of medicated shampoos are for dandruff issues, bald issues, scalp issues, and hair loss issues. Dandruff is a scalp condition characterized by flaking of the skin on the scalp, often accompanied by itching. It includes various treatments for conditions such as dandruff and seborrheic dermatitis, psoriasis, tinea capitis, head lice, and allergic reactions, distributed through supermarkets or hypermarkets, pharmacies and drug stores, department stores, online, and others.

What Is The Medicated Shampoo Market Growth Forecast?

The medicated shampoo market size is expected to see strong growth in the next few years. It will grow to $17.86 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising prevalence of psoriasis and fungal infections, growing demand for personalized scalp care, expansion of online sales channels, increasing focus on preventive hair loss treatment, innovation in active ingredient formulations. Major trends in the forecast period include rising demand for targeted scalp treatment solutions, growing preference for dermatologist-recommended shampoos, increased adoption of herbal and natural medicated formulations, expansion of over-the-counter medicated hair care products, higher consumer awareness of scalp health and hygiene.

Global Medicated Shampoo Market Segmentation

1) By Type: Anti-Dandruff, Antifungal, Anti-Hair Loss, Antibacterial Or Scalp Treatment 2) By Distribution Channel: Pharmacies Or Drugstores, Supermarkets Or Hypermarkets, Online Retail Or E-commerce, Specialty Stores 3) By Application: Dandruff, Seborrheic Dermatitis, Psoriasis, Fungal Infections, Other Applications 4) By End-User: Adults, Children, Men, Women Subsegments: 1) By Anti-Dandruff: Zinc Pyrithione, Ketoconazole, Coal-Tar, Herbal/Natural 2) By Antifungal: Ketoconazole-Based, Selenium Sulfide-Based, Ciclopirox-Based 3) By Anti-Hair Loss: Minoxidil-Based, Biotin Or Natural Extracts, DHT Blockers 4) By Antibacterial Or Scalp Treatment: Salicylic Acid, Climbazole, Tea Tree Oil

What Is The Driver Of The Medicated Shampoo Market?

The increasing prevalence of scalp disorders is expected to propel the growth of the medicated shampoo market going forward. Scalp disorders refer to conditions that affect the skin on the scalp, causing symptoms such as itching, flaking, inflammation, irritation, or hair loss. The prevalence of scalp disorders is rising due to increasing environmental pollution, chemical exposure, stress, and lifestyle factors that disrupt the scalp’s natural barrier and microbiome. The medicated shampoo market supports this trend by offering formulations with antifungal, anti-inflammatory, and keratolytic agents that treat underlying causes and promote scalp healing. For instance, in February 2025, according to the American Academy of Dermatology Association, a US-based non-profit professional organization, acne, one of the most common dermatological conditions affects 0.05 billion people each year in the United States, highlighting the growing burden of skin and scalp-related disorders requiring targeted therapeutic care. Therefore, the increasing prevalence of scalp disorders is driving the growth of the medicated shampoo industry.

Key Players In The Global Medicated Shampoo Market

Major companies operating in the medicated shampoo market are Johnson & Johnson, The Procter & Gamble Company, Unilever PLC, Kao Corporation, Cipla Limited, The Himalaya Company, Avalon Natural Products Inc., Ederma Pharma India Private Limited, Elegant Cosmed Private Limited, Luxica Pharma Inc., Yaxon Biocare Pvt. Ltd., Art Naturals Inc., Nioxin Research Laboratories Inc., Sulfur 8 Inc., Summer Laboratories Inc., Mars Medisoap Private Limited, Staple Pharmaceuticals Pvt. Ltd., Astonea Labs Limited, Ketopoz Pharmaceuticals Pvt. Ltd., Maylizz Biotech Private Limited

Global Medicated Shampoo Market Trends and Insights

Major companies operating in the medicated shampoo market are focusing on developing innovative formulations, such as medicated dry shampoo, to address growing consumer demand for convenient, waterless scalp-care solutions that effectively manage dermatological conditions. Medicated dry shampoo refers to a specialized hair-care product that blends traditional oil-absorbing dry-shampoo functionality with therapeutic active ingredients to treat scalp disorders such as dandruff, seborrheic dermatitis, and psoriasis while allowing application without water. For instance, in November 2024, Raven Innovations LLC, a US-based pharmaceutical and personal-care company, launched RestoraScalp, the world’s first medicated dry shampoo formulated to treat scalp conditions including dandruff, seborrheic dermatitis, and psoriasis. This innovative product features 2% salicylic acid as the active therapeutic ingredient, a soothing botanical blend containing chamomile, olive leaf, and green tea extracts, and a vegan, cruelty-free, and fragrance-free formulation suitable for all skin types, offering an effective waterless solution for scalp treatment on non-wash days.

What Are Latest Mergers And Acquisitions In The Medicated Shampoo Market?

In February 2025, Cosette Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Mayne Pharma Group Limited for $430 million. With this acquisition, Cosette Pharmaceuticals aims to expand its leadership in women’s health and dermatology by combining its strong product portfolio with Mayne Pharma’s proven commercial and manufacturing capabilities, enhancing global patient access and driving innovation in specialty pharmaceuticals. Mayne Pharma Group Limited is a Australia-based specialty pharmaceutical company that specializes in developing provides a medicated shampoos.

Regional Outlook

North America was the largest region in the medicated shampoo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Medicated Shampoo Market?

The medicated shampoo market consists of sales of anti-dandruff shampoos, anti-itch shampoos, psoriasis shampoos, oily scalp shampoos, and scalp infection shampoos. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medicated Shampoo Market Report 2026?

The medicated shampoo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medicated shampoo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.